


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
GNLX
Genelux
$4.55
GNLX Price Performance
$4.64 (-1.94%)
$4.75 (-4.21%)
$3.19 (+42.63%)
$2.89 (+57.44%)
GNLX has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

GNLX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
GNLX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GNLX Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is GNLX current stock price?
What are GNLX stock strengths?
What is GNLX Risk Level?
What is GNLX market cap and volume?
What is GNLX current Stock IQ?
Should I buy GNLX stock right now?
Is GNLX a Strong Buy right now?
What does a 'Strong Buy' rating mean for GNLX?
What does a 'Strong Sell' rating mean for GNLX?
What factors influence GNLX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
GNLX
Genelux
Current Price
$4.55
Stock Insights
Not Enough Information

GNLX Price Performance
$4.64 (-1.94%)
$4.75 (-4.21%)
$3.19 (+42.63%)
$2.89 (+57.44%)
GNLX Analysts Opinion
GNLX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Future
Future
![]()
GNLX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
GNLX Street Sentiment is extremely bullish and have negative views on the near-term outlook
GNLX has Medium risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

Low volume

High volatilty

Average key support and resistance price levels
GNLX Stock IQ
GNLX Latest Analysis
Genelux Corp Appoints Jason Litten CMO . (RTTNews) - Genelux Corp. (GNLX) a clinical-stage immuno-oncology company Friday announced that it has appointed Jason Litten as Chief Medical Officer effective January 2.
Fri Jan 2, 2026
Genelux Corporation Announces Appointment of Jason Litten M.D. as Chief Medical Officer. WESTLAKE VILLAGE Calif. Jan. 02 2026 (GLOBE NEWSWIRE) -- NASDAQ: GNLX) a late clinical-stage immuno-oncology company today announced the appointment of Jason Litten M.D. as Chief Medical Officer effective January 2 2026. Dr. Litten will oversee all clinical development and medical strategy as the company advances Olvi-Vec through multiple upcoming pivotal milestones.
Fri Jan 2, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GNLX Stock trends
GNLX Stock performance
GNLX Stock analysis
GNLX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.